Author/Authors :
Xu، نويسنده , , Huanbin and Feely، نويسنده , , Stephanie L. and Wang، نويسنده , , Xiaolei and Liu، نويسنده , , David X. and Borda، نويسنده , , Juan T. and Dufour، نويسنده , , Jason and Li، نويسنده , , Weiwei and Aye، نويسنده , , Pyone P. and Doxiadis، نويسنده , , Gaby G. and Khosla، نويسنده , , Chaitan and Veazey، نويسنده , , Ronald S. and Sestak، نويسنده , , Karol، نويسنده ,
Abstract :
Celiac disease (CD) is an autoimmune disorder caused by intolerance to dietary gluten. The interleukin (IL)-17 and IL-22 function as innate regulators of mucosal integrity. Impaired but not well-understood kinetics of the IL-17/22 secretion was described in celiac patients. Here, the IL-17 and IL-22-producing intestinal cells were studied upon their in vitro stimulation with mitogens in class II major histocompatibility complex-defined, gluten-sensitive rhesus macaques. Pediatric biopsies were collected from distal duodenum during the stages of disease remission and relapse. Regardless of dietary gluten content, IL-17 and IL-22-producing cells consisted of CD4 + and CD8 + T lymphocytes as well as of lineage-negative (Lin −) cells. Upon introduction of dietary gluten, capability of intestinal T cells to secrete IL-17/22 started to decline (p < 0.05), which was paralleled with gradual disruption of epithelial integrity. These data indicate that IL-17/22-producing cells play an important role in maintenance of intestinal mucosa in gluten-sensitive primates.
Keywords :
Rhesus , Autoimmunity , tissue transglutaminase , Celiac disease , Th17